RxDoctor Payments DataLook up a doctor →

Maureen Schuller, PA

Surgical · Lancaster, PANPI 1093018046

Payments from drug & device makers

$12,205in general payments, 2019–2025

Across 816 payments — averaging $14.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Dexcom, Inc.$1K
  • Lilly USA, LLC$1K
  • AstraZeneca$827
  • AbbVie$584
  • Amgen$546
  • plus $5K from 37 others

What the payments were for

  • Food & beverage$12,178100%
  • Education$270%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$12,205 in reported general payments places this provider in the 95th percentile of 626 surgical providers in Pennsylvania.

See all surgical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$58,975
Medicare patients
232
Services billed
1,490

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide232$363,870
MounjaroTirzepatide181$224,287
JardianceEmpagliflozin158$174,934
TrulicityDulaglutide129$161,676
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/791$84,262
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog96$78,696
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog117$64,455
Humulin R U-500 KwikpenInsulin Regular, Human23$54,385
Tresiba Flextouch U-100Insulin Degludec51$42,557
FarxigaDapagliflozin Propanediol23$36,380
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog24$35,754
Lantus SolostarInsulin Glargine,hum.Rec.Anlog199$33,876
TradjentaLinagliptin28$33,541
Humalog Kwikpen U-100Insulin Lispro104$30,325
ProliaDenosumab15$25,679

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog, Fiasp$2,278$398,901300 claims
Lilly USA, LLCMounjaro, Trulicity, Humalog$1,337$398,493340 claims
Boehringer IngelheimJardiance, Tradjenta$103$208,475186 claims
Sanofi-aventis U.S. LLCAdmelog, Soliqua 100-33, Lantus$380$46,24084 claims
AstraZenecaFarxiga$827$36,38023 claims
AmgenProlia$546$25,67915 claims
MerckJanumet Xr$311$12,34911 claims
AbbVieSynthroid$584$10,297121 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid$418$5,222474 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 626 surgical providers in Pennsylvania.

Other surgical in Lancaster

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →